Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Summary

Current therapies for Metastatic Pancreatic Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Metastatic Pancreatic Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Metastatic Pancreatic Cancer.

Timeline

Start

1996-02-27

Primary completion

1999-12-31

Completion

1999-12-31

Drugs

Indications